Eric M. van der Aa
Directeur Général chez Hep-Art Medical Devices BV
Provenance du réseau au premier degré de Eric M. van der Aa
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Organon BioSciences NV
 Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Eric M. van der Aa via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Pantarhei Bioscience BV
 Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
| University of Utrecht | College/University | Doctorate Degree | |
| Université Libre de Bruxelles | College/University | Corporate Officer/Principal | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| Pantarhei Oncology BV | Founder | ||
| Oxytone Bioscience BV | Chairman | ||
| Maastricht University | College/University | Graduate Degree |
Statistiques
Internationale
| Pays-Bas | 8 |
| Belgique | 3 |
| Etats-Unis | 2 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 4 |
| Commercial Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chairman | 3 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| President | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Eric M. van der Aa
- Connexions Sociétés
